Perceptive brings unmatched depth in central imaging/BICR (Blinded Independent Central Reading) and advanced imaging biomarker analysis in clinical, translational and preclinical. We supported more than 3,800 clinical trials including more than 400 regulatory approvals in all therapeutic area and possessed inhouse and more than 1,300 board-certified radiologist network all around the worlds. Our scientific and medical teams-including leaders who helped create Imaging criteria- design and oversee complex imaging strategies spanning RECIST, iRECIST, irRECIST, PERCIST, PCWG3, advanced PSMA (Oncology), Lugano (Hematology) PDFF, Muscle Fat Infiltration, Muscle Volume Z-score (Metabolic and Musculoskeletal), and advanced PSMA and radioligant therapy clinical development and read criteria. Perceptive can support feature extraction, advanced segmentation, and AI?driven analytics, with validated workflows suitable in either exploratory or regulatory environments. Our radiomics toolkit spans automated lesion triage, volumetrics, longitudinal feature analysis, and AI?assisted segmentation?deployed across CT, MRI, PET, and SPECT modalities.